ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Аналоги ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Найдите более доступные аналоги и дженерики для ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG.
Активный ингредиент: abacavir hydrochloride, lamivudine
Описание товара
About ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG is a prescription medicine supplied in film-coated tablet form. This pharmaceutical product is formulated to contain a fixed-dose combination of active ingredients designed for specific therapeutic regimens as prescribed by a qualified healthcare professional. Each package provides the exact formulation standards required for patient treatment compliance according to approved medical guidelines.
Key Benefits & Uses
- Contains a fixed combination of two active pharmaceutical ingredients in a single oral dose.
- Supplied as film-coated tablets for oral administration.
- Manufactured to meet strict quality and dosage consistency standards.
Active Ingredient & Action
The active substances in this medicine are ABACAVIR CLORHIDRATO and LAMIVUDINA. These components work together within the body according to their established pharmacological mechanisms to support the targeted therapeutic indications determined by your treating physician.
Important Notes
Use ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG strictly as directed by your doctor or pharmacist. Read the package leaflet thoroughly before starting treatment. Store the medicine in its original container in a cool, dry place out of the reach of children. Consult a healthcare professional immediately if you experience any adverse effects or have questions about your prescribed dosage regimen.
Оценки посетителей
Помогите другим — оцените полезность этой страницы.
Оценок пока нет — будьте первым.